REDHAWK LAUNCHES SALES OF ITS RE-DESIGNED SANDD PRO™
REDHAWK LAUNCHES SALES OF
Company Initiates Plan to Reduce PPE Inventories
LAFAYETTE, LA -- November 25, 2020 --
InvestorsHub NewsWire -- RedHawk Holdings
SNDD) ("RedHawk" or the
"Company"), a diversified holding
company primarily engaged in sales and
of medical devices, announced
completed the re-design of the SANDD Pro™, the Company's needle
incineration unit specifically engineered for use by hospitals, clinics, medical practitioners,
retirement homes and in other medical facilities. The Company has now started
Commenting on the
launch of the SANDD Pro™, G. Darcy Klug,
RedHawk's Chairman of the Board and Chief Financial Officer, said
"The 2020 calendar year has definitely been
thus far. This year has demanded patience, resilience, durability and flexibility.
We started the
2020 calendar year with increasing sales of our line of
devices resulting from
recognition and acceptance of our line of
mini™ needle incineration devices by school systems and first
responders in Louisiana, Texas, California, Oklahoma, Wyoming,
Mississippi, Minnesota and Nevada.
In December 2019, a
novel strain of coronavirus surfaced in Wuhan, China,
throughout the world. On March 11, 2020 the World Health
Organization characterized the spread of COVID-19 as a "pandemic".
The significant reach of COVID-19 resulted in a widespread public
health issue that affected the economies worldwide,
affected our business
and our customer
base. We experienced an immediate decrease in demand for
of SANDD mini™ needle incineration
devices by school systems and first responders. Further, future demand for our newly
released SANDD Pro™ was delayed until hospitals,
clinics and physicians could resume normal
operations. But, as a result of the pandemic,
we were able
to immediately pivot our sales efforts
expanded our line of medical device sales efforts to include
personal protective equipment
("PPE"). We also capitalized on these
business interruptions to modify and broaden our engineering
re-design objectives of the SANDD Pro™ to improve the immediate capability of the
incinerate 18-gauge needles, a necessity to address
needs of hospitals and clinics.
In November 2020,
we decided to return our primary business focus to our main product
line – SANDD™ needle incineration
devices. While we will continue to offer for sale certain PPE
products, we plan to significantly reduce our PPE
inventories during the three month period ending December 31, 2020.
In some cases, this plan may result in sales at prices less than
our original inventory cost, but we believe returning our
focus to our original business model is the correct long-term course of
# # #
About RedHawk Holdings Corp.
RedHawk Holdings Corp., formerly Independence Energy Corp., is
a diversified holding company which, through its subsidiaries, is
engaged in the sales and distribution of
medical devices, sales of branded
generic pharmaceutical drugs, commercial real
estate investment and leasing, sales of point of
entry full-body security systems, and specialized
financial services. Through its medical
products business unit, the Company sells
the Sharps and Needle Destruction Device
(SANDD™), WoundClot Surgical - Advanced Bleeding
Control, and the Carotid Artery
Digital Non-Contact Thermometer. Through our
United Kingdom based subsidiary, we manufacture and market branded
generic pharmaceuticals. RedHawk Energy holds the
exclusive U.S. manufacturing and distribution rights for the Centri
Controlled Entry System, a unique, closed cabinet, nominal dose
transmission full-body x-ray scanner. For more
information, please visit: http://www.redhawkholdingscorp.com
Cautionary Statement Regarding Forward-Looking
This release may contain forward-looking statements.
Forward-looking statements are all statements other than statements
of historical fact. Statements contained in this release
that are not historical facts may be deemed to be forward-looking
statements. The words "anticipate," "may," "can," "plans,"
"believes," "estimates," "expects," "projects," "targets,"
"intends," "likely," "will," "should," "to be,"
"potential" and any similar expressions are intended to identify
those assertions as forward-looking statements.
Investors are cautioned that forward-looking statements are
inherently uncertain. Actual performance and results,
including results related to the
Company's re-design of the SANDD Pro™,
may differ materially from that projected or suggested herein
due to certain risks and uncertainties. In evaluating
forward-looking statements, you should consider the various factors
which may cause actual results to differ materially from
any forward-looking statements including those listed in the "Risk
Factors" section of our latest annual report on Form
10-K. Further, the Company may make changes to its
business plans that could or will affect its results.
Investors are cautioned that the Company will undertake no
obligation to update any forward-looking statements.
Klug, Chairman and CFO
Prince, Managing Director